Zions Bancorporation’s BeOne Medicines Ltd ONC Stock Holding History

Zions Bancorporation’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11	Closed	-$2K	–	1176
2022 Q1	$2K	Sell	11 -12	-52%	-$2.55K	﹤0.01%	1074
2021 Q4	$6K	Hold	23	–	–	﹤0.01%	835
2021 Q3	$8K	Hold	23	–	–	﹤0.01%	775
2021 Q2	$8K	Sell	23 -6	-21%	-$1.99K	﹤0.01%	774
2021 Q1	$10K	Hold	29	–	–	﹤0.01%	715
2020 Q4	$7K	Sell	29 -3	-9%	-$826	﹤0.01%	749
2020 Q3	$9K	Buy	32 +3	+10%	+$705	﹤0.01%	706
2020 Q2	$5K	Buy	29 +26	+867%	+$4.23K	﹤0.01%	759
2020 Q1	$0	Buy	+3	New	+$469	﹤0.01%	1009
2019 Q1	–	Sell	-24	Closed	-$3K	–	997
2018 Q4	$3K	Buy	+24	New	+$3.18K	﹤0.01%	406

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Zions Bancorporation's ONC Position: Q2 2022 in Review

Zions Bancorporation sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 11 shares — an estimated $2K sold.

Zions Bancorporation first reported a position in ONC in Q4 2018 and held it in 10 quarters. The position peaked at $10K in Q1 2021. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

Zions Bancorporation reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
Zions Bancorporation sold 11 BeOne Medicines Ltd shares in Q2 2022, an estimated $2K.
Zions Bancorporation first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 10 quarters.
Zions Bancorporation's BeOne Medicines Ltd position peaked at $10K in Q1 2021.
235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Zions Bancorporation's 13F filing for Q2 2022, filed 5 Aug 2022.